sprite-preloader
Anzeige
Mehr »
Dienstag, 24.04.2018 Börsentäglich über 12.000 News von 574 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Passende Knock-Outs zu Ihrer Suchanfrage (Anzeige)
Erweiterte
Suche
lynx
Ad hoc-Mitteilungen

Aktuelle News von FierceBiotech

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
MoNews of Note-A skin implant to detect cancer; nonhormonal birth control for men
MoAmid troubles, ex-Rosetta CEO Berlin parachuted in as new Advaxis head
MoConsent decree wipes $24M off Philips' first-quarter earnings
MoFDA still not happy with Kamada inhaled AAT drug
MoSynthetic Biologics loses breakthrough status after FDA discovers death imbalance in trial data
MoTargeting heart disease by focusing on a protein that dilates blood vessels
MoTerumo's Vascutek and Bolton Medical merge to form single aortic device company
MoAfter Kerrisdale predictions of failure, Prothena dumps AL amyloidosis drug
MoSanofi diabetes research chief takes CSO post at Grünenthal
MoOrion to sell diagnostics unit for $200M
MoFDA floats relaxation of regulations to encourage use of mass spectrometry to identify microorganisms
FrDicerna to pay Alnylam $15M plus stock to settle RNAi trade secrets suit
FrA compound from immune cells could treat psoriasis, other autoimmune diseases
FrGene editing shows promise in combating HIV reservoirs
FrUCB offers $370M for Proximagen's epilepsy spray, with NDA to follow
FrBiogen pays Ionis $1B to form discovery-stage pact
FrTrayt debuts mobile app to track and help treat autism, ADHD
FrFDA approves heart monitor unanimously rejected by expert panel in 2016
FrBenevolentAI bags $115M to fuel AI-enabled R&D push
FrChutes & Ladders-GlaxoSmithKline poaches Roche executive for pipeline deal-making
FrMorphoSys supersizes IPO, bagging $208M for cancer R&D
FrFDA 'conflicted' on Lilly and Incyte's refiled baricitinib
FrAfter questioning Lilly/Incyte's baricitinib, FDA reviewer jumps ship to AstraZeneca
DoIn a unanimous vote, FDA advisory committee waves through GW Pharma's cannabinoid Epidiolex
DoGrail to seek an additional $1B in funding before Hong Kong IPO, report says